Longevity
Voyager’s single-dose gene therapy cuts tau by 75%
New six-month data strengthen the case for a one-time Alzheimer’s treatment as Voyager prepares to begin human trials later this year. What if Alzheimer’s care can be provided in the form of a single infusion given once? What if the biggest breakthrough is finally finding a reliable way to reach the brain in the first […] The post Voyager’s single-dose gene therapy cuts tau by 75% appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →